COVID-19 changed the way we practice medicine and reshaped how we relate with each other in crowded and closed environments, including hospitals, schools, offices and public transportation. It has prompted extensive and multidisciplinary studies on the physiology and transmission of viral infections in different settings, and changed how healthcare workers and first respondents protect themselves and other individuals from respiratory viral infections. It has also enhanced the study of other respiratory viral infections in high-risk populations, such as transplant, cancer and aging patients, amongst others. The accelerated pathways in developing several COVID-19 vaccines has also increased research in other vaccines for respiratory viruses, such as influenza and syncytial respiratory virus.
In this topic we would like to address how COVID-19 has changed our understanding of viral respiratory infections and the delivery of healthcare and public policies. We will also review some of the more recent advances in vaccines for respiratory viruses, challenges for their development and implementation, and the impact of respiratory viral infections in high-risk populations.
In this research topic we would like to address:
1. Furthering our understanding of respiratory virus dynamics and transmission
2. Medical attention of patients with respiratory infections in hospitals, emphasizing environmental, engineering and non-pharmacological preventive measures
3. The importance of face masks and behavioural science in the hospital and beyond medical facilities
4. Influenza, COVID-19, respiratory syncytial virus and other respiratory viruses in solid organ transplant
5. Influenza, COVID-19, respiratory syncytial virus and other respiratory viruses in bone marrow transplant and cancer patients
6. The future of vaccinations for influenza, COVID-19 and respiratory syncytial virus
COVID-19 changed the way we practice medicine and reshaped how we relate with each other in crowded and closed environments, including hospitals, schools, offices and public transportation. It has prompted extensive and multidisciplinary studies on the physiology and transmission of viral infections in different settings, and changed how healthcare workers and first respondents protect themselves and other individuals from respiratory viral infections. It has also enhanced the study of other respiratory viral infections in high-risk populations, such as transplant, cancer and aging patients, amongst others. The accelerated pathways in developing several COVID-19 vaccines has also increased research in other vaccines for respiratory viruses, such as influenza and syncytial respiratory virus.
In this topic we would like to address how COVID-19 has changed our understanding of viral respiratory infections and the delivery of healthcare and public policies. We will also review some of the more recent advances in vaccines for respiratory viruses, challenges for their development and implementation, and the impact of respiratory viral infections in high-risk populations.
In this research topic we would like to address:
1. Furthering our understanding of respiratory virus dynamics and transmission
2. Medical attention of patients with respiratory infections in hospitals, emphasizing environmental, engineering and non-pharmacological preventive measures
3. The importance of face masks and behavioural science in the hospital and beyond medical facilities
4. Influenza, COVID-19, respiratory syncytial virus and other respiratory viruses in solid organ transplant
5. Influenza, COVID-19, respiratory syncytial virus and other respiratory viruses in bone marrow transplant and cancer patients
6. The future of vaccinations for influenza, COVID-19 and respiratory syncytial virus
